Aberrant and persistent activation of the PI3K/AKT/mTORC1 signaling pathway plays an important role in controlling the proliferation and survival of tumor cells in various types of malignancies, including DLBCL [108]. This evidence concerns the gene AKT1 and diffuse large B-cell lymphoma.